Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Maria Vannucchi

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Plos One|May 10, 2019
NanoR: A user-friendly R package to analyze and compare nanopore sequencing dataDavide Bolognini, Niccolò Bartalucci, Alessandra Mingrino, et al.
Pathology, Research and Practice|December 7, 2014
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterizationRoberto Castelli, Massimo Cugno, Umberto Gianelli, et al.
Leukemia|November 9, 2019
Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirinTiziano Barbui, Arianna Ghirardi, Alessandro Maria Vannucchi, et al.
Haematologica|May 30, 2020
An agenda for future research projects in polycythemia vera and essential thrombocythemiaTiziano Barbui, Alessandro Maria Vannucchi, Paola Guglielmelli, et al.
Haematologica|February 14, 2007
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosisCostanza Bogani, Paola Guglielmelli, Elisabetta Antonioli, et al.
American Journal of Hematology|May 1, 2017
A life-threatening ruxolitinib discontinuation syndromeGiacomo Coltro, Francesco Mannelli, Paola Guglielmelli, et al.
American Journal of Hematology|May 21, 2016
MR Imaging in non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosisLinda Calistri, Lisa Pieri, Raffaella Santi, et al.
Annals of Hematology|March 3, 2026
From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN studyTiziano Barbui, Jürgen Thiele, Alberto Alvarez-Larran, et al.
Hematological Oncology|May 6, 2017
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinibAnnalisa Pacilli, Tiziana Fanelli, Carmela Mannarelli, et al.
Hemoglobin|October 15, 2024
δβ-Thalassemia and α-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?Cristina Giubbilei, Simona D'Angelo, Ilaria Fotzi, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Plos One|May 10, 2019
NanoR: A user-friendly R package to analyze and compare nanopore sequencing dataDavide Bolognini, Niccolò Bartalucci, Alessandra Mingrino, et al.
Pathology, Research and Practice|December 7, 2014
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterizationRoberto Castelli, Massimo Cugno, Umberto Gianelli, et al.
Leukemia|November 9, 2019
Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirinTiziano Barbui, Arianna Ghirardi, Alessandro Maria Vannucchi, et al.
Haematologica|May 30, 2020
An agenda for future research projects in polycythemia vera and essential thrombocythemiaTiziano Barbui, Alessandro Maria Vannucchi, Paola Guglielmelli, et al.
Haematologica|February 14, 2007
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosisCostanza Bogani, Paola Guglielmelli, Elisabetta Antonioli, et al.
American Journal of Hematology|May 1, 2017
A life-threatening ruxolitinib discontinuation syndromeGiacomo Coltro, Francesco Mannelli, Paola Guglielmelli, et al.
American Journal of Hematology|May 21, 2016
MR Imaging in non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosisLinda Calistri, Lisa Pieri, Raffaella Santi, et al.
Annals of Hematology|March 3, 2026
From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN studyTiziano Barbui, Jürgen Thiele, Alberto Alvarez-Larran, et al.
Hematological Oncology|May 6, 2017
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinibAnnalisa Pacilli, Tiziana Fanelli, Carmela Mannarelli, et al.
Hemoglobin|October 15, 2024
δβ-Thalassemia and α-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?Cristina Giubbilei, Simona D'Angelo, Ilaria Fotzi, et al.
Pageof 13